Navigation Links
Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
Date:12/9/2008

CHESHIRE, Conn., Dec. 9 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), was observed by investigators to reduce blood measures associated with undiagnosed blood clots and inflammation in patients with PNH.

A separate study found that Soliris was observed to reduce indicators of pulmonary artery hypertension (PAH) in patients with paroxysmal nocturnal hemoglobinuria (PNH), according to a new analysis of clinical trial data. Both sets of data were presented in oral sessions yesterday at the 50th Annual Meeting of the American Society of Hematology.

"The common, severe and progressive clinical consequences of PNH are becoming more apparent as researchers gain more experience and basic knowledge with regard to this disease," said Leonard Bell, M.D., Chief Executive Officer of Alexion.

Blood Markers of Thrombin Generation and Inflammation

Research titled "Eculizumab Therapy Results in Rapid and Sustained Decreases in Markers of Thrombin Generation and Inflammation in Patients with PNH" was presented yesterday in an oral session at the ASH annual meeting by Ilene Ceil Weitz, M.D., Assistant Clinical Professor of Medicine, Jane Anne Nohl Division of Hematology, Keck School of Medicine of the University of Southern California.

Recently published research showed that patients with PNH were observed to have 92 percent fewer blood clots (thromboses) during treatment with Soliris (1) compared to the period of time prior to Soliris treatment. To better understand the mechanism for this observed reduction, researchers used highly sensitive laboratory tests to track levels of blood markers in order to determine the effect of Soliris on markers of thrombin generation and inflammation among ei
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
2. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
3. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
6. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
7. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
8. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
9. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
10. NIST studies how new helium ion microscope measures up
11. SpectraCell Laboratories Now Measures Vitamin C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 Interventional cardiologist Tony Farah, MD, ... (AGH) Cardiovascular Institute have helped pioneer many breakthroughs ... (CAD) over the past three decades, from new ... and coronary artery stent implantation. , Today, AGH officials ... prominent role in the study of a novel, first-of-its ...
(Date:5/20/2013)... Kitware, a leader in data visualization, today unveils a ... of hospital costs across the United States . The ... of “Medicare Provider Charge Data,” a dataset of pricing ... Centers for Medicare & Medicaid Services. , The wide ... the country has sparked considerable controversy; however, it is ...
(Date:5/19/2013)... MA (PRWEB) May 19, 2013 The ... social media training online, has proudly announced that the ... small business has surpassed 175,000 views on YouTube. The ... social media and SEO tips and training for small ... my students find the YouTube tips helpful for their ...
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
Breaking Biology Technology:Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4Kitware Enables Interactive Exploration of CMS Medicare Data 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2
... Sept. 24 Cyberonics, Inc. (Nasdaq: CYBX ) today ... JMP Securities 4th Annual Healthcare Focus Conference in New York on ... will host a webcast of the presentation live and by replay ... available for 90 days following the conference. Presentation slides will ...
... CAMBRIDGE, Mass., Sept. 24 Peptimmune, Inc. ("Peptimmune"), a ... a research and development collaboration with the Walter Reed Army ... (NMRC), Silver Spring, MD to evaluate the Company,s proprietary DEEP(TM) ... and point-of-care diagnostics. , , After ...
... YORK, Sept. 24 Reportlinker.com announces that a new market ... In Vitro Diagnostics in a ... , , http://www.reportlinker.com/p0119227/In-Vitro-Diagnostics-in-a-Recession-IVD-Market-Forecasts-Analysis-and-Success-Strategies.html ... commonly asserted that in vitro diagnostics is a recession-proof industry. ...
Cached Biology Technology:Cyberonics to Present at JMP Securities 4th Annual Healthcare Focus Conference 2Peptimmune to Collaborate on Dengue Virus Vaccine and Point-Of-Care Diagnostic With Two DOD Biomedical Research Facilities 2Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 2Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 3Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 4Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 5Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 6Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 7Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 8Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 9
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Endocrine Society (ENDO) 95th Annual Meeting in San ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... ENDO 2013 Annual Meeting. , Awards are given ...
(Date:5/16/2013)... have used ancient shorelines to predict the stability of today,s ... high shoreline from three million years ago, for example ... thought to be evidence of a high sea level due ... led many scientists to think that if the world,s largest ... just the same in our modern, progressively warming world. ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2
... of the most devastating diseases in sub-Saharan Africa almost ... sickness, or trypanosomiasis, largely succumbed to heroic public health ... past several decades, because of post-colonial turmoil, the catastrophic ... the Democratic Republic of the Congo, the Sudan and ...
... annual migration time on Cape Cod again, the time of ... thousands. It's a sign of spring to the fishermen who ... here at the Marine Biological Laboratory (MBL), it triggers an ... world, who return here faithfully every summer to study the ...
... not only is vital to the immune system's ability to ... an unexpected location within the cell, causing researchers to rethink ... , Researchers at UT Southwestern Medical Center said their findings ... viral diseases such as the flu, hepatitis, West Nile virus ...
Cached Biology News:Compound might defeat African sleeping sickness, clinical trial beginning this month 2Compound might defeat African sleeping sickness, clinical trial beginning this month 3Compound might defeat African sleeping sickness, clinical trial beginning this month 4Gifts from the sea 2Gifts from the sea 3New protein vital for immune response is found in surprise location 2New protein vital for immune response is found in surprise location 3
The epitope is specific for TASK and is not present in any other known proteins tested so far.,SPECIES REACTIVITIES: The epitope is also highly conserved between mouse and rat (17/18 residues iden...
...
Anti-Mouse MIP-1g, Biotin (Polyclonal) (rabbit IgG)...
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
Biology Products: